Regis Healthcare has named Andrew Kinkade as its new Managing Director and Chief Executive Officer, ending a search that began when Dr Linda Mellors announced her departure in December 2025.
Kinkade, who currently serves as Managing Director of Bupa Villages & Aged Care, is slated to take the helm on 20 July 2026. He succeeds Mellors, who will complete her notice period on 19 June 2026.
Why This Appointment Matters for Regis Healthcare
The leadership change arrives at a sensitive moment for Regis and the broader aged care sector.
Regis reported an 18% revenue increase to AUD 668 million in the first half of FY2026, but underlying EBITDA margin slipped to 10.6% from 12% in the prior period. That combination, solid top-line growth alongside margin pressure, reflects the structural funding challenges every large aged care operator is navigating right now.
Australia’s aged care reform overhaul, which kicked in from November 2025, has reshaped how providers get paid and how residents are charged. Whoever leads Regis through this period needs both financial discipline and a genuine understanding of care delivery.
Kinkade appears to fit that brief.
Who Is Andrew Kinkade?
Andrew Kinkade, incoming Managing Director & CEO, Regis Healthcare Limited [LinkedIn]
He brings over two decades of experience across aged care, healthcare, private equity, and investment banking.
At Bupa Villages & Aged Care, he leads a team of 8,000 people across 57 locations. The ASX announcement credits him with delivering operational and cultural transformation, improving clinical care outcomes, and navigating regulatory reform, all qualities Regis explicitly needed in its next leader.
Prior to Bupa, Kinkade held executive roles at Bupa Dental Care, Catholic Healthcare, and National Home Doctor Service. Earlier in his career, he worked in strategy consulting at Bain & Company and in private equity at Macquarie Group in London.
Academically, he holds a Bachelor of Laws (First Class Honours) and a Bachelor of Accounting from the University of Technology Sydney, and is a qualified Chartered Accountant, Solicitor, and member of the Australian Institute of Company Directors.
Key facts about the new Regis Healthcare CEO:
- Start date: 20 July 2026
- Fixed remuneration: $900,000 per annum, inclusive of superannuation
- Short-term incentive: up to 50% of fixed remuneration
- Long-term incentive: up to 100% of fixed remuneration in Performance Rights
- Sign-on equity award: Performance Rights to the value of $1,600,000, vesting over 36 months
The sign-on award compensates Kinkade for forfeiting unvested long-term incentives at Bupa, and is subject to shareholder approval at the Company’s next Annual General Meeting.
What the Board Said
Regis Chairman Graham Hodges was direct in his assessment.
“Andrew is a values-based leader with deep sector experience,” Hodges said. “He brings an exceptional blend of operational leadership, strategic rigour and financial capability. His track record in delivering growth whilst leading complex transformations in highly regulated, people-intensive businesses makes him ideally suited to this role.”
Kinkade himself pointed to the personal dimension of the role.
“Aged care is an industry I am deeply passionate about,” he said. “It is a genuine opportunity to make a meaningful difference to the lives of older Australians and their families.”
What Happens Next for Regis
Regis is one of Australia’s largest aged care providers, with approximately 8,400 beds across 74 homes. The Company also delivers home care services and operates retirement villages.
The transition period between now and 20 July gives Kinkade time to get across the business before formally assuming control. Mellors’ handover concludes 19 June, which means there is a short interim gap the board will need to manage.
Australia’s aged care crisis continues to intensify, with staffing costs, regulatory compliance, and AN-ACC funding structures all weighing on providers. Kinkade’s background in turning around complex, people-heavy operations at Bupa gives him a credible starting point.
Regis Healthcare Limited (ASX: REG) shares will be watched closely in the days following this announcement, given the market’s strong negative reaction when Mellors’ resignation was first disclosed. Shares fell 2.6% to AUD 7.13 when Dr Mellors’ exit was announced in December 2025.
Whether Andrew Kinkade’s appointment restores that confidence is the next question for investors.
Also Read: Megaport Bags a $35.4 Million Compute Contract and the Numbers Behind It Tell a Bigger Story
FAQ
Q: Who is the new CEO of Regis Healthcare?
A: Andrew Kinkade has been appointed Managing Director and Chief Executive Officer of Regis Healthcare Limited (ASX: REG). He joins from Bupa Villages & Aged Care, where he currently serves as Managing Director. His official start date is 20 July 2026.
Q: Why did Regis Healthcare’s previous CEO leave?
A: Dr Linda Mellors announced her resignation in December 2025 to pursue a career opportunity in a different industry. She served as CEO for more than six years. Her notice period concludes on 19 June 2026.
Q: What is Andrew Kinkade’s background?
A: Kinkade has over 20 years of experience in aged care, healthcare, private equity, and investment banking. He holds qualifications from the University of Technology Sydney, is a qualified Chartered Accountant and Solicitor, and has previously worked at Bain & Company and Macquarie Group.
Q: What is Regis Healthcare’s total remuneration package for its new CEO?
A: The fixed remuneration is $900,000 per annum. Short-term incentives can reach up to 50% of that amount, while long-term incentives can reach up to 100%, awarded as Performance Rights. A sign-on equity award of $1,600,000 in Performance Rights, vesting over three years, was also approved by the board, subject to shareholder approval.
Q: How large is Regis Healthcare?
A: Regis is one of Australia’s largest aged care operators. It provides services to over 10,000 older Australians across residential homes, home care hubs, day therapy and respite centres, and retirement villages, with more than 13,000 employees.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Regis Healthcare Limited (ASX: REG) is a publicly listed company and its share price may fluctuate. Readers should conduct their own research and consult a licensed financial adviser before making any investment decisions.
Source: https://www.regis.com.au/newsroom-new-ceo-appointment-andrew-kinkade/
Last modified: April 29, 2026
